Top Posts
MedX Health Corp. (TSX-V:MDX) Closes Private Placement of...
Regeneron (NASDAQ:REGN) Releases Phase 3 Trial Results for...
Quantum BioPharma’s MS Imaging Study Reaches Midpoint, Shows...
Context Therapeutics (Nasdaq:CNTX) Secures Full Rights to CT-202...
Merck’s Sacituzumab Tirumotecan Meets Endpoints in Phase 3...
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Q1 2026 Financial Results...

feature stories

MindBio Therapeutics (CSE:MBIO) Pioneers AI Voice Analysis for Intoxication Detection
CTT Pharmaceutical Holdings (OTCQB:CTTH) Signs LOI for Strategic Partnership
DiagnosTear Technologies (CSE:DTR) Licenses CLARIFY Eye Imaging Platform for Needle-Free Blood Analysis
MindBio Therapeutics (CSE:MBIO) Harnesses AI and Voice Analysis for Intoxication Detection
DiagnosTear Technologies (CSE:DTR) Announces AGM Results

Breaking News

BreakingRegulatory
Context Therapeutics (Nasdaq:CNTX) Secures Full Rights to CT-202 with Buyout Agreement
Breaking
Inspira Technologies (NASDAQ:IINN) Receives $580,000 Order from NYU Langone Hospital
Breaking
Maris-Tech (NASDAQ:MTEK) Launches Compact AI-Enabled Vision Solution
BreakingRegulatory
FibroBiologics (Nasdaq:FBLG) Files Patent for Oral Fibroblast Delivery System
Breaking
Silexion (NASDAQ:SLXN) Receives Approval for Phase 2/3 Clinical Trial of SIL204 in Pancreatic Cancer
Breaking
GeoVax (Nasdaq: GOVX) Highlights Need for Diversified Vaccine Supply Amid Global Health Concerns
BreakingR&D - Therapy
Protara Therapeutics (Nasdaq:TARA) Announces Positive 12-Month Data for TARA-002 in Bladder Cancer Trial
BreakingEarningsRegulatory
Indaptus Therapeutics (Nasdaq:INDP) Announces Q1 2026 Financial Results and Corporate Update
BreakingR&D - Therapy
Palvella Therapeutics (Nasdaq:PVLA) Announces New Data from Phase 2 TOIVA Trial of QTORIN™ rapamycin in Cutaneous Venous Malformations
BreakingEarningsRegulatory
Sensei Biotherapeutics (Nasdaq:SNSE) Reports First Quarter 2026 Financial Results and Provides Corporate Update
BreakingEvents
Organon (NYSE:OGN) to Present Data at ISPOR 2026 on Women’s Health and More
BreakingEarningsFinancingsRegulatory
Lifeward (Nasdaq:LFWD) Completes Strategic Transaction and Receives $10 Million Financing

More Breaking News…

Biotech2

DAYFILE:

Market News

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.